These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 3285568)
1. Long-term perspective of hematologic malignancies. Cheson BD Trans Assoc Life Insur Med Dir Am; 1988; 71():198-220. PubMed ID: 3285568 [No Abstract] [Full Text] [Related]
2. [Cytostatic polychemotherapy in the elderly]. Heinz R Dtsch Med Wochenschr; 1986 May; 111(19):761-2. PubMed ID: 3698857 [No Abstract] [Full Text] [Related]
3. [What is reliable in the therapy of hematologic diseases? I. Hemoblastosis and malignant lymphoproliferative diseases]. Havemann K; Schmidt M; Malchow H; Sodomann CP Internist (Berl); 1970 Dec; 11(12):441-9. PubMed ID: 4993105 [No Abstract] [Full Text] [Related]
5. [Clinical research on the antipyretic effects of indomethacin in systemic hemopathies]. Marcolongo R; Bianco G; Di Paolo N; Bravi A Minerva Med; 1970 Oct; 61(82):4532-41. PubMed ID: 5273365 [No Abstract] [Full Text] [Related]
6. [Complications during treatment of blood diseases with corticosteroid hormonal preparations]. Latysh VN; Khludeev NI Sov Med; 1974 Jun; 37(6):91-5. PubMed ID: 4527064 [No Abstract] [Full Text] [Related]
7. Acute leukemia in children. Model for the development of scientific methodology for clinical therapeutic research in cancer. Frei E Cancer; 1984 May; 53(10):2013-25. PubMed ID: 6367931 [No Abstract] [Full Text] [Related]
8. Changes in survival in haematological malignancies. Holmes FF East Afr Med J; 1972 Feb; 49(2):67-74. PubMed ID: 4505629 [No Abstract] [Full Text] [Related]
9. [The treatment of chronic hemoblastosis with new cytostatic agents]. Quattrin N Minerva Med; 1966 Mar; 57(25):1141-3. PubMed ID: 5932017 [No Abstract] [Full Text] [Related]
10. [Rehabilitation and cure of patients with hemoblastoses]. Gerhartz H Dtsch Med J; 1968 Mar; 19(5):161-3. PubMed ID: 4887782 [No Abstract] [Full Text] [Related]
12. Current status and new vistas in combination chemotherapy. Frei E Mt Sinai J Med; 1985 Jun; 52(6):460-4. PubMed ID: 3875026 [No Abstract] [Full Text] [Related]
13. [Status and trends in hematology]. Stobbe H Z Arztl Fortbild (Jena); 1986; 80(18):741-4. PubMed ID: 3544527 [No Abstract] [Full Text] [Related]
14. [Results using current therapy programs with acute leukemias in adults]. Perilov AA; Volkova MA; Frenkel' MA Vestn Akad Med Nauk SSSR; 1986; (5):18-23. PubMed ID: 3460275 [No Abstract] [Full Text] [Related]
15. Current chemotherapeutic treatment strategies in childhood acute nonlymphocytic leukemia. Lampkin BC; Masterson M; Sambrano JE; Heckel JL; Jones G Semin Oncol; 1987 Dec; 14(4):397-406. PubMed ID: 3321444 [No Abstract] [Full Text] [Related]
16. Chemotherapy of haematological malignancies. Prognostic significance. Klener P Acta Univ Carol Med Monogr; 1979; 90():7-127. PubMed ID: 400423 [No Abstract] [Full Text] [Related]
17. Amsacrine with high-dose cytarabine in acute leukemia. Zittoun R; Bury J; Stryckmans P; Lowenberg B; Peetermans M; Rozendaal KY; Haanen C; Kerkhofs M; Jehn U; Willemze R Cancer Treat Rep; 1985 Dec; 69(12):1447-8. PubMed ID: 3841026 [No Abstract] [Full Text] [Related]
18. [Long-term follow-up of Hodgkin's disease and unfavorable type of non-Hodgkin's lymphoma]. Sampi K; Maseki N; Sakurai M; Hattori M Rinsho Ketsueki; 1988 Feb; 29(2):144-8. PubMed ID: 3385941 [No Abstract] [Full Text] [Related]